Lannett Co Inc (LCI) Shares are Down -2.33%

Lannett Co Inc (LCI) : During the past 4 weeks, traders have been relatively bearish on Lannett Co Inc (LCI), hence the stock is down -0.51% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.3% relative to the S&P 500. The 4-week change in the price of the stock is -0.13% and the stock has fallen -2.33% in the past 1 week.

Lannett Company, Inc. is up 36.13% in the last 3-month period. Year-to-Date the stock performance stands at -23.65%. The stock has recorded a 20-day Moving Average of 2.31% and the 50-Day Moving Average is 9.37%.


Lannett Co Inc (NYSE:LCI): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $30.45 and $30.19 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $30.93. The buying momentum continued till the end and the stock did not give up its gains. It closed at $30.63, notching a gain of 0.13% for the day. The total traded volume was 426,247 . The stock had closed at $30.59 on the previous day.

Also, Deutsche Bank initiates coverage on Lannett Co Inc (NYSE:LCI). The shares have now been rated Hold by the stock experts at the ratings house. The rating by the firm was issued on June 29, 2016.

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Companys products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.